Abstract
Over a 5-year period, 1980-1985, 39 patients from a dialysis population of over 400 treated at this centre experienced major difficulties in achieving adequate access for dialysis by conventional techniques (i.e. arteriovenous fistula or CAPD). This study has evaluated the long-term results of a new approach to circulatory access, central venous catheterisation (CVC) for so called "high risk" patients. CVC consists of inserting a single-lumen CAPD-type silastic catheter into the right atrium via an external or internal jugular vein. Forty-seven catheters have been inserted into 39 uraemic patients. All patients had failed on, or were unsuitable for, conventional access to haemodialysis or CAPD. Ten patients (26%) had previous failed renal transplants. The median duration of catheter use was 7 months (range 1-60 months) and a total of 6500 high-performance dialyses have been performed using this technique. No patient has died of catheter-related problems. The catheters were easily managed by nurses and well tolerated by the patients. The incidence of complications among patients was low: displacement (1), catheter thrombosis (2), skin exit-site infections (5), septicaemia (2). Central venous catheterisation is a method of providing safe and reliable long-term vascular access which is immediately usable by high-risk patients who have either failed on or are unsuitable for conventional circulatory access.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.